Iron sucrose injection
Products billed under this code include Iron Sucrose, Venofer.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Iron Sucrose, Venofer.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Iron Sucrose | Sandoz Inc. | 00781-3485-95 | 500 | $112.00 |
| Iron Sucrose | Sandoz Inc. | 00781-3485-96 | 1250 | $280.00 |
| Iron Sucrose | Sandoz Inc. | 00781-3486-95 | 1000 | $224.00 |
| Iron Sucrose | Sandoz Inc. | 00781-3486-96 | 2500 | $560.00 |
| Iron Sucrose | Sandoz Inc. | 00781-3487-14 | 1000 | $224.00 |
| Iron Sucrose | Sandoz Inc. | 00781-3487-94 | 200 | $44.80 |
| Iron Sucrose | Mylan Institutional LLC | 67457-0638-10 | 1000 | $224.00 |
| Iron Sucrose | Mylan Institutional LLC | 67457-0638-25 | 2500 | $560.00 |
| Iron Sucrose | Mylan Institutional LLC | 67457-0639-10 | 1000 | $224.00 |
| Iron Sucrose | Mylan Institutional LLC | 67457-0957-99 | 500 | $112.00 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Iron Sucrose | International Medication Systems, LTD | 76329-9200-01 | 500 | $112.00 |
| Iron Sucrose | International Medication Systems, LTD | 76329-9201-01 | 1000 | $224.00 |
| Iron Sucrose | International Medication Systems, LTD | 76329-9201-05 | 2500 | $560.00 |
| Iron Sucrose | International Medication Systems, LTD | 76329-9202-05 | 1000 | $224.00 |
| Venofer | American Regent, Inc. | 00517-2310-05 | 1000 | $224.00 |
| Venofer | American Regent, Inc. | 00517-2325-10 | 500 | $112.00 |
| Venofer | American Regent, Inc. | 00517-2340-10 | 1000 | $224.00 |
| Venofer | American Regent, Inc. | 00517-2340-25 | 2500 | $560.00 |
| Venofer | American Regent, Inc. | 00517-2340-99 | 1000 | $224.00 |
| Venofer | Fresenius Medical Care North America | 49230-0530-10 | 500 | $112.00 |
| Venofer | Fresenius Medical Care North America | 49230-0530-25 | 1250 | $280.00 |
| Venofer | Fresenius Medical Care North America | 49230-0534-10 | 1000 | $224.00 |
| Venofer | Fresenius Medical Care North America | 49230-0534-25 | 2500 | $560.00 |
| Venofer | A-S Medication Solutions | 50090-4541-00 | 100 | $22.40 |
| Venofer | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1568-01 | 100 | $22.40 |
| Venofer | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1568-03 | 1000 | $224.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.224 | −$0.003 | 1 MG | Iron sucrose injection | v1, posted September 17, 2026 |
| 3Q26 | $0.227 | +$0.004 | 1 MG | Iron sucrose injection | v1, posted September 15, 2026 |
| 2Q26 | $0.223 | −$0.013 | 1 MG | Iron sucrose injection | v1, posted September 15, 2026 |
| 1Q26 | $0.236 | +$0.007 | 1 MG | Iron sucrose injection | v1, posted September 15, 2026 |
| 4Q25 | $0.229 | +$0.005 | 1 MG | Iron sucrose injection | v1, posted September 8, 2026 |
| 3Q25 | $0.224 | −$0.013 | 1 MG | Iron sucrose injection | v1, posted March 10, 2026 |
| 2Q25 | $0.237 | +$0.011 | 1 MG | Iron sucrose injection | v1, posted March 10, 2026 |
| 1Q25 | $0.226 | −$0.007 | 1 MG | Iron sucrose injection | v1, posted December 19, 2025 |
| 4Q24 | $0.233 | +$0.005 | 1 MG | Iron sucrose injection | v1, posted June 11, 2025 |
| 3Q24 | $0.228 | −$0.001 | 1 MG | Iron sucrose injection | v1, posted June 11, 2025 |
| 2Q24 | $0.229 | +$0.008 | 1 MG | Iron sucrose injection | v1, posted March 11, 2025 |
| 1Q24 | $0.221 | +$0.016 | 1 MG | Iron sucrose injection | v1, posted December 19, 2024 |
| 4Q23 | $0.205 | −$0.001 | 1 MG | Iron sucrose injection | v1, posted October 10, 2024 |
| 3Q23 | $0.206 | +$0.001 | 1 MG | Iron sucrose injection | v1, posted June 5, 2024 |
| 2Q23 | $0.205 | −$0.018 | 1 MG | Iron sucrose injection | v1, posted February 23, 2024 |
| 1Q23 | $0.223 | +$0.019 | 1 MG | Iron sucrose injection | v1, posted December 6, 2023 |
| 4Q22 | $0.204 | +$0.001 | 1 MG | Iron sucrose injection | v1, posted June 22, 2023 |
| 3Q22 | $0.203 | −$0.021 | 1 MG | Iron sucrose injection | v1, posted June 9, 2023 |
| 2Q22 | $0.224 | +$0.003 | 1 MG | Iron sucrose injection | v1, posted December 14, 2022 |
| 1Q22 | $0.221 | −$0.007 | 1 MG | Iron sucrose injection | v1, posted June 8, 2022 |
| 4Q21 | $0.228 | +$0.004 | 1 MG | Iron sucrose injection | v1, posted June 2, 2022 |
| 3Q21 | $0.224 | −$0.006 | 1 MG | Iron sucrose injection | v1, posted June 2, 2022 |
| 2Q21 | $0.23 | −$0.118 | 1 MG | Iron sucrose injection | v1, posted March 1, 2022 |
| 1Q21 | $0.348 | – | 1 MG | Iron sucrose injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.